申请人:Klopfenstein Rees Sean
公开号:US20050154011A1
公开(公告)日:2005-07-14
Compounds of formula (I):
are effective in the treatment of protein tyrosine phosphatase (PTPase) mediated disorder such as diabetes.
公式(I)的化合物在治疗蛋白
酪氨酸磷酸酶(
PTPase)介导的疾病,如糖尿病方面具有有效性。